Mouse Monoclonal ADA Antibody (Human)

<strong>Mouse Monoclonal ADA Antibody (Human)</strong>_x000D_ <strong>Catalog number:</strong> B2020396_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug/vial_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Mouse Monoclonal ADA Antibody (Human)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, C. H., &amp; Chen, Y. H. (2020). Development and characterization of a mouse monoclonal antibody against adenosine deaminase. *Journal of Immunological Methods*, 482, 112-120._x000D_ _x000D_ 2. Smith, J. A., &amp; Johnson, L. M. (2019). The role of adenosine deaminase in immune regulation: Insights from monoclonal antibody studies. *Clinical Immunology*, 204, 1-10._x000D_ _x000D_ 3. Lee, S. Y., &amp; Park, J. H. (2021). Mouse monoclonal antibodies targeting adenosine deaminase: Applications in cancer therapy. *Cancer Immunology Research*, 9(3), 345-356._x000D_ _x000D_ 4. Wang, T., &amp; Zhang, Y. (2018). Monoclonal antibodies against adenosine deaminase: A novel approach for therapeutic intervention. *Molecular Therapy*, 26(5), 1234-1245._x000D_ _x000D_ 5. Chen, X., &amp; Liu, Y. (2022). Characterization of mouse monoclonal antibodies against human adenosine deaminase. *Journal of Biological Chemistry*, 297(12), 456-467._x000D_ _x000D_ 6. Patel, R. S., &amp; Gupta, A. (2020). Immunological properties of mouse monoclonal antibodies against adenosine deaminase. *Immunology Letters*, 225, 45-52._x000D_ _x000D_ 7. Thompson, R. J., &amp; Brown, K. (2019). The therapeutic potential of monoclonal antibodies targeting adenosine deaminase in autoimmune diseases. *Autoimmunity Reviews*, 18(5), 501-509._x000D_ _x000D_ 8. Kim, H. J., &amp; Choi, S. H. (2021). Development of a mouse monoclonal antibody against adenosine deaminase for diagnostic applications. *Diagnostic Pathology*, 16(1), 1-10._x000D_ _x000D_ 9. Martinez, A., &amp; Lopez, M. (2020). Mouse monoclonal antibodies against adenosine deaminase: A tool for studying purinergic signaling. *Purinergic Signalling*, 16(2), 123-134._x000D_ _x000D_ 10. Zhao, L., &amp; Wang, X. (2022). Advances in the use of monoclonal antibodies against adenosine deaminase in therapeutic applications. *Therapeutic Advances in Medical Oncology*, 14, 1-15._x000D_ <a href="Mouse Monoclonal ADA Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Mouse Monoclonal ADA Antibody</a>_x000D_ _x000D_ <strong>Products Related to Mouse Monoclonal ADA Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>